Stage-related decorin and versican expression in human laryngeal cancer

Anticancer Research

Volumn 28, Issue 1 A, 2008, Pages 245-252

  Stylianou, M ^a   Skandalis, S S ^a,b   Papadas, T A ^a   Mastronikolis, N S ^a   Theocharis, D A ^a   Papageorgakopoulou, N ^a   Vynios, D H ^a,c  

^a UNIVERSITY OF PATRAS   (Greece)

^b LUDWIG INSTITUTE FOR CANCER RESEARCH   (Sweden)

^c UNIVERSITY OF PATRAS   (Greece)

Author keywords

Aggrecan; Decorin; Immunohistochemistry; Proteoglycan; RT PCR; Versican; Western blotting

Indexed keywords

AGGRECAN; DECORIN; PROTEOGLYCAN; VERSICAN;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; LARYNX CANCER; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ADULT; AGED; AGED, 80 AND OVER; AGGRECANS; CARCINOMA, SQUAMOUS CELL; EXTRACELLULAR MATRIX PROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; LARYNGEAL NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROTEOGLYCANS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; VERSICANS;

EID: 40549095277     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Iozzo RV: Matrix proteoglycans. From molecular design to cellular function. Annu Rev Biochem 67: 609-652, 1998.
2. Skandalis SS, Theocharis AD, Vynios DH, Theocharis DA and Papageorgakopoulou N: Proteoglycans in human laryngeal cartilage. Identification of proteoglycan types in successive cartilage extracts with particular reference to aggregating proteoglycans. Biochimie 86: 221-229, 2004.
3. Skandalis SS, Stylianou M, Vynios DH, Papageorgakopoulou N and Theocharis DA: The stuctural and compositional changes of glycosaminoglycans are closely associated with tissue type in human laryngeal cancer. Biochimie 2007, in press.
4. Skandalis SS, Theocharis AD, Theocharis DA, Papadas TA, Vynios DH and Papageorgakopoulou N: Matrix proteoglycans are markedly affected in advanced laryngeal squamous cell carcinoma. Biochim Biophys Acta 1689: 152-161, 2004.
5. Skandalis SS, Theocharis DA. Papageorgakopoulou N and Vynios DH: The extractability of extracellular matrix components as a marker of cartilage remodeling in laryngeal squamous cell carcinoma. Biochim Biophys Acta 1721: 81-88, 2005.
6. Skandalis SS, Theocharis AD, Vynios DH, Papageorgakopoulou N, Hjerpe A, Karamanos NK and Theocharis DA: Cartilage aggrecan undergoes significant compositional and structural alterations during laryngeal cancer. Biochim Biophys Acta 1760: 1046-1053, 2006.
7. Skandalis SS, Theocharis AD, Papageorgakopoulou N, Vynios DH and Theocharis DA: The increased accumulation of structurally modified versican and decorin is related with the progression of laryngeal cancer. Biochimie 88: 1135-1143, 2006.
8. Pukkila MJ, Kosunen AST, Virtaniemi JA, Kumpulainen EJ, Johansson RT, Kellokoski JK, Nuutinen J and Kosma VM: Versican expression in pharyngeal squamous cell carcinoma: an immunohistochemical study. J Clin Pathol 57: 735-739, 2004.
9. Voutilainen K, Anttila M, Sillanpaa S, Tammi R, Tammi M, Saarikoski S and Kosma VM: Versican in epithelial ovarian cancer: relation to hyaluronan, clinicopathologic factors and prognosis. Int J Cancer 107: 359-364, 2003.
10. Suwiwat S, Ricciardelli C, Tammi R, Tammi M, Auvinen P, Kosma VM, LeBaron RG, Raymond WA, Tilley WD and Horsfall DJ: Expression of extracellular matrix components versican, chondroitin sulfate, tenascin, and hyaluronan, and their association with disease outcome in node-negative breast cancer. Clin Cancer Res 10: 2491-2498, 2004.
11. Pirinen R, Leinonen T, Bohm J, Johansson R, Ropponen K, Kumpulainen E and Kosma VM: Versican in nonsmall cell lung cancer: relation to hyaluronan, clinicopathologic factors, and prognosis. Human Pathol 36: 44-50, 2005.
12. Ricciardelli C, Mayne K, Sykes PJ, Raymond WA, McCaul K, Marshall VR and Horsfall DJ: Elevated levels of versican but not decorin predict disease progression in early-stage prostate cancer. Clin Cancer Res 4: 963-971, 1998.
13. Pukkila M, Kosunen A, Ropponen K, Virtaniemi J, Kellokoski J, Kumpulainen E, Pirinen R, Nuutinen J, Johansson R and Kosma V-M: High stromal versican expression predicts unfavourable outcome in oral squamous cell carcinoma. J Clin Pathol 60: 267-272, 2007.
14. Kodama J, Hasengaowa, Kusumoto T, Seki N, Matsuo T, Ojima Y, Nakamura K, Hongo A and Hiramatsu Y: Prognostic significance of stromal versican expression in human endometrial cancer. Ann Oncol 18: 269-274, 2007.
15. Kodama J, Hasengaowa, Kusumoto T, Seki N, Matsuo T, Nakamura K, Hongo A and Hiramatsu Y: Versican expression in human cervical cancer. Eur J Cancer 43: 1460-1466, 2007.
16. Wight TN: Versican: a versatile extracellular matrix proteoglycan in cell biology. Curr Opin Cell Biol 14: 617-623, 2002.
17. Wu YJ, Lapierre D, Wu J, Yee AJ and Yang BB: The interaction of versican with its binding partners. Cell Res 15: 483-494, 2005.
18. LaPierre DP, Lee DY, Li SZ, Xie YZ, Zhong L, Sheng W, Deng Z and Yang BB: The ability of versican to simultaneously cause apoptotic resistance and sensitivity. Cancer Res 67: 4742-4750, 2007.
19. Ang LC, Zang Y, Cao L, Yang BL, Young B, Kiani C, Lee V, Allan K and Yang BB: Versican enhances locomotion of astrocytoma cells and reduces cell adhesion through its G1 domain. J Neuropathol Exp Neurol 58: 597-605, 1999.
20. Yang BL, Zhang Y, Cao L and Yang BB: Cell adhesion and proliferation mediated through the G1 domain of versican. J Cell Biochem 72: 110-120, 1999.
21. Zheng PS, Wen J, Ang LC, Sheng W, Viloria-Petit A, Wang Y, Wu Y, Kerbel RS and Yang BB: Versican/PG-M G3 domain promotes tumor growth and angiogenesis. FASEB J 18: 754-756, 2004.
22. Timar J, Lapis K, Dudas J, Sebestyen A, Kopper L and Kovalszky I: Proteoglycans and tumor progression: Janus-faced molecules with contradictory functions in cancer. Semin Cancer Biol 12: 173-186, 2002.
23. Santra M, Skorski T, Calabretta B, Lattime EC and Iozzo RV: De novo decorin gene expression supresses the malignant phenotype in human colon cancer cells. Proc Natl Acad Sci USA 92: 7016-7020, 1995.
24. DeLuca A, Santra M, Baldi A, Giordano A and Iozzo RV: Decorin induced growth suppression is associated with up-regulation of p21, an inhibitor of cyclin-dependent kinases. J Biol Chem 271: 18961-18965, 1996.
25. Iozzo RV: Decorin is a biological ligand for the epidermal growth factor receptor. J Biol Chem 274: 4489-4492, 1999.
26. Seidler DG, Goldoni S, Agnew C, Cardi C, Thakur ML, Owens RT, McQuillan DJ and Iozzo RV: Decorin protein core inhibits in vivo cancer growth and metabolism by hindering epidermal growth factor receptor function and triggering apoptosis via caspase-3 activation. J Biol Chem 281: 26408-26418, 2006.
27. Reed CC, Waterhouse A, Kirby S, Kay P, Owens RT, McQuillan DJ and Iozzo RV: Decorin prevents metastatic spreading of breast cancer. Oncogene 24: 1104-1110, 2005.
28. Vynios DH, Vamvakas SS, Kalpaxis DL and Tsiganos CP: Aggrecan immobilization onto polystyrene plates through electrostatic interactions with spermine. Anal Biochem 260: 64-70, 1998.
29. Christopoulos TA, Papageorgakopoulou N, Theocharis DA, Mastronikolis NS, Papadas TA and Vynios DH: Hyaluronidase and CD44 hyaluronan receptor expression in squamous cell laryngeal carcinoma. Biochim Biophys Acta 1760: 1039-1045, 2006.
30. Sessions RB, Harrison LB and Forastiere AA: Tumors of the larynx and hypopharynx. In: Cancer: Principles and Practice of Oncology. DeVita VT, Hellman S and Rosenberg SA (eds.). 6th Edition, Philadelphia, Lippincott Williams & Wilkins, pp. 861-886, 2001.
31. Papadas TA, Stylianou M, Mastronikolis NS, Papageorgakopoulou N, Skandalis S, Goumas P, Theocharis DA and Vynios DH: Alterations in the content and composition of glycosaminoglycans in human laryngeal carcinoma. Acta Otolaryngol 122: 330-337, 2002.
32. Christopoulos TA, Papageorgakopoulou N, Theocharis DA, AIetras AJ, Tsiganos CP, Papadas TA, Mastronikolis NS, Goumas P and Vynios DH: Diagnostic and classification value of metalloproteinases in squamous human laryngeal carcinoma. Int J Oncol 25: 481-485, 2004.
33. Christopoulos TA, Papageorgakopoulou N, Ravazoula P, Mastronikolis NS, Papadas TA, Theocharis DA and Vynios DH: Expression of metalloproteinases and their tissue inhibitors in squamous cell laryngeal carcinoma. Oncol Rep 18: 855-860, 2007.
34. Schwartz GJ and Wenig BL: Clinical Considerations for Neoplasms of the Larynx. In: Head and Neck Pathology with Clinical Correlations. Philadelphia, Churchill Livingstone, pp. 330-360, 1998.